Advertisement
Home Tags Food & Drug Administration

Tag: Food & Drug Administration

Venclexta (venetoclax) has been approved by the U.S. Food and Drug Administration to treat chronic lymphocytic leukemia characterized by a specific chromosomal abnormality

FDA Approves Venclexta for CLL With 17p Deletion

0
Drug sanctioned for chronic lymphocytic leukemia in patients with a specific chromosomal abnormality
The first leadless

FDA Approves First Leadless Pacemaker

0
Eliminates need to repair wire lead in typical pacemakers that can malfunction
Diabetes medications containing saxagliptin and alogliptin may raise the risk of heart failure

FDA Issues New Warning for Two Diabetes Medications

0
Drugs containing saxagliptin or alogliptin may be linked to heart failure risk
The U.S. Food and Drug Administration has approved its second-ever "biosimilar" drug

FDA Approves Inflectra as ‘Biosimilar’ to Remicade

0
For adults with Crohn's, rheumatoid arthritis, or psoriasis
Defitelio (defibrotide sodium) has been approved by the U.S. Food and Drug Administration to treat a rare

FDA Approves First Tx for Disease Linked to Stem Cell Transplant

0
Hepatic veno-occlusive disease is rare, but fatal
Continuing their push to combat the nation's epidemic of opioid abuse

FDA Wants Generic Opioids to Be Abuse-Deterrent

0
One more step to combat the epidemic of opioid abuse
Cinqair (reslizumab) has been approved by the U.S. Food and Drug Administration to treat severe asthma among adults 18 and older.

FDA Approves Cinqair for Severe Asthma

0
Lab-developed interleukin-5 antagonist monoclonal antibody helps reduce blood levels of eosinophils
The U.S. Food and Drug Administration has announced that immediate-release opioid pain medications will get new boxed warnings about the dangers of misuse.

FDA Orders Enhanced Warning Labels on Opioid Pain Medications

0
New labeling rules mostly aimed at immediate-release versions of opioids
Anthim (obiltoxaximab) has been approved by the U.S. Food and Drug Administration to treat inhalational anthrax.

FDA Approves Anthim for Treating Inhalation Anthrax

0
Anthim, combined with certain antibacterial drugs, designed to neutralize anthrax toxins
U.S. health officials on Friday gave tentative approval to a field test in the Florida Keys of mosquitoes genetically modified to help curb the spread of the Zika virus.

FDA Gives Tentative Approval to Tests of Gene-Modified Mosquitos

0
Agency says testing the insects in Florida Keys poses little risk to people, animals, the environment